As our data indicated that BTF3 was involved in regulation of DNA replication and DNA damage repair in prostate cancer cells, we next examined the correlation of BTF3 expression with treatment response to cisplatin, a DNA crosslinking agent that causes DNA damage3–5. This evidence concerns the gene BTF3 and prostate carcinoma.